Physician

James M Patton, MD

According to 2025 Medicare claims, James Patton, MD (NPI: 1518945690) practices neurology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE NEUROLOGY SPECIALISTS, PA (NPI: 1588614168; TIN: 200912649) and primary practice location at 28806-0366. Patton is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Patton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 914 traditional Medicare patients, billed 113,014 HCPCS/CPT codes, and received $1,283,969 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 7,217 prescription claims across 1,150 beneficiaries totaling $1,866,968 in drug costs, led by Nuplazid (Pimavanserin Tartrate). 2023 DME data shows 18 claims. Open Payments data shows 103 records totaling $159,483. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $4,332,389 to $1,866,968. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $70,409 to $9,639.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,343	96,159	$862,671
2016	1,342	107,037	$961,334
2017	1,301	100,801	$997,139
2018	1,262	105,008	$1,022,838
2019	1,305	112,042	$1,151,296
2020	1,279	112,842	$1,232,631
2021	1,273	115,518	$1,349,897
2022	1,305	113,236	$1,212,612
2023	1,182	121,021	$1,143,988
2024	914	113,014	$1,283,969

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,185	11,557	$4,332,389
2016	1,223	12,490	$4,334,029
2017	1,215	12,301	$4,580,616
2018	1,234	12,510	$4,501,278
2019	1,331	13,127	$5,084,184
2020	1,300	12,593	$4,773,580
2021	1,288	10,893	$3,440,379
2022	1,260	9,027	$2,644,887
2023	1,192	7,561	$2,028,295
2024	1,150	7,217	$1,866,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	47	$5,923
2016	N/R	123	$11,166
2017	N/R	67	$3,657
2018	N/R	22	$1,886
2019	N/R	96	$12,345
2020	N/R	49	$2,783
2021	N/R	11	$851
2022	N/R	17	$1,040
2023	N/R	18	$725
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	111	111	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	400	508	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	208	233	$55
95874	Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle	110	327	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	450	599	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nuplazid	Pimavanserin Tartrate	46	1,620	$276,008
Botox	Onabotulinumtoxina	175	14,700	$229,661
Tysabri	Natalizumab	15	420	$141,830
Rytary	Carbidopa/Levodopa	65	2,989	$91,723
Ubrelvy	Ubrogepant	45	1,066	$57,018

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	100	$2,770	MDD US Operations, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$156,713	Sage Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James M. Patton, MD?

Tedicare shows public-source Medicare data for James M. Patton, MD (NPI 1518945690), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James M. Patton, MD have ACO affiliation data?

James M. Patton, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to James M. Patton, MD?

James M. Patton, MD is linked to ASHEVILLE NEUROLOGY SPECIALISTS, PA (billing NPI 1588614168) in the available physician profile data.

Does James M. Patton, MD have Open Payments data?

James M. Patton, MD has 103 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.